Accendra Health Inc (ACH) stock
ACHNYSEWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3098% below fair value
$0.13−0.01 (-9.59%)
Close on Nov 13, 2026Market cap $10.15MP/E –Yield –
Accendra Health total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Accendra Health's total debt was $1.75B at Sep 30, 2026. For fiscal 2025 it was $2.05B, up 11.3% from the year before. Over ten years it grew 13.6% a year on average. The highest annual figure on record is $2.50B in fiscal 2022.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.05B | +11.3% |
| FY2024 | Dec 31, 2024 | $1.84B | -12.2% |
| FY2023 | Dec 31, 2023 | $2.10B | -16.1% |
| FY2022 | Dec 31, 2022 | $2.50B | +163.9% |
| FY2021 | Dec 31, 2021 | $947.54M | -7.6% |
| FY2020 | Dec 31, 2020 | $1.03B | -34.2% |
| FY2019 | Dec 31, 2019 | $1.56B | -7.0% |
| FY2018 | Dec 31, 2018 | $1.68B | +82.8% |
| FY2017 | Dec 31, 2017 | $917.36M | +61.1% |
| FY2016 | Dec 31, 2016 | $569.39M | -0.7% |
| FY2015 | Dec 31, 2015 | $573.52M | -6.6% |
| FY2014 | Dec 31, 2014 | $613.81M | +183.9% |
| FY2013 | Dec 31, 2013 | $216.24M | -0.6% |
| FY2012 | Dec 31, 2012 | $217.59M | +1.4% |
| FY2011 | Dec 31, 2011 | $214.56M | +1.7% |
| FY2010 | Dec 31, 2010 | $210.91M | +1.2% |
| FY2009 | Dec 31, 2009 | $208.42M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.75B | -17.0% |
| Q2 FY2026 | Jun 30, 2026 | $1.72B | -13.1% |
| Q1 FY2026 | Mar 31, 2026 | $2.10B | +8.0% |
| Q4 FY2025 | Dec 31, 2025 | $2.05B | +11.3% |
| Q3 FY2025 | Sep 30, 2025 | $2.12B | +12.2% |
| Q2 FY2025 | Jun 30, 2025 | $1.98B | -5.0% |
| Q1 FY2025 | Mar 31, 2025 | $1.95B | -9.6% |
| Q4 FY2024 | Dec 31, 2024 | $1.84B | -12.2% |
| Q3 FY2024 | Sep 30, 2024 | $1.88B | -10.8% |
| Q2 FY2024 | Jun 30, 2024 | $2.08B | -9.8% |
| Q1 FY2024 | Mar 31, 2024 | $2.15B | -8.8% |
| Q4 FY2023 | Dec 31, 2023 | $2.10B | -16.1% |
| Q3 FY2023 | Sep 30, 2023 | $2.11B | -17.0% |
| Q2 FY2023 | Jun 30, 2023 | $2.31B | -10.0% |
| Q1 FY2023 | Mar 31, 2023 | $2.36B | -10.4% |
| Q4 FY2022 | Dec 31, 2022 | $2.50B | +163.9% |
| Q3 FY2022 | Sep 30, 2022 | $2.55B | +165.5% |
| Q2 FY2022 | Jun 30, 2022 | $2.57B | +154.5% |
| Q1 FY2022 | Mar 31, 2022 | $2.64B | +168.5% |
| Q4 FY2021 | Dec 31, 2021 | $947.54M | -7.6% |
| Q3 FY2021 | Sep 30, 2021 | $959.49M | -12.7% |
| Q2 FY2021 | Jun 30, 2021 | $1.01B | -20.6% |
| Q1 FY2021 | Mar 31, 2021 | $981.34M | -33.9% |
| Q4 FY2020 | Dec 31, 2020 | $1.03B | -34.2% |
| Q3 FY2020 | Sep 30, 2020 | $1.10B | -29.2% |
| Q2 FY2020 | Jun 30, 2020 | $1.27B | -21.8% |
| Q1 FY2020 | Mar 31, 2020 | $1.48B | -11.9% |
| Q4 FY2019 | Dec 31, 2019 | $1.56B | -7.0% |
| Q3 FY2019 | Sep 30, 2019 | $1.55B | -5.3% |
| Q2 FY2019 | Jun 30, 2019 | $1.62B | -2.7% |
| Q1 FY2019 | Mar 31, 2019 | $1.69B | +87.8% |
| Q4 FY2018 | Dec 31, 2018 | $1.68B | +82.8% |
| Q3 FY2018 | Sep 30, 2018 | $1.64B | +78.8% |
| Q2 FY2018 | Jun 30, 2018 | $1.67B | +188.3% |
| Q1 FY2018 | Mar 31, 2018 | $897.07M | +59.0% |
| Q4 FY2017 | Dec 31, 2017 | $917.36M | +61.1% |
| Q3 FY2017 | Sep 30, 2017 | $917.26M | – |
| Q2 FY2017 | Jun 30, 2017 | $579.12M | – |
| Q1 FY2017 | Mar 31, 2017 | $564.15M | – |
| Q4 FY2016 | Dec 31, 2016 | $569.39M | – |
See a number that looks wrong?